Metabolomic characterization of colorectal cancer cell lines highlighting stage-specific alterations during cancer progression
- PMID: 33842285
- PMCID: PMC8022234
- DOI: 10.34172/bi.2021.22
Metabolomic characterization of colorectal cancer cell lines highlighting stage-specific alterations during cancer progression
Abstract
Introduction: Metabolomic studies on various colorectal cancer (CRC) cell lines have improved our understanding of the biochemical events underlying the disease. However, the metabolic profile dynamics associated with different stages of CRC progression is still lacking. Such information can provide further insights into the pathophysiology and progression of the disease that will prove useful in identifying specific targets for drug designing and therapeutics. Thus, our study aims to characterize the metabolite profiles in the established cell lines corresponding to different stages of CRC. Methods: Metabolite profiling of normal colon cell lines (CCD 841 CoN) and CRC cell lines corresponding to different stages, i.e., SW 1116 (stage A), HT 29 and SW 480 (stage B), HCT 15 and DLD-1 (stage C), and HCT 116 (stage D), was carried out using liquid chromatography-mass spectrometry (LC-MS). Mass Profiler Professional and Metaboanalyst 4.0 software were used for statistical and pathway analysis. METLIN database was used for the identification of metabolites. Results: We identified 72 differential metabolites compared between CRC cell lines of all the stages and normal colon cells. Principle component analysis and partial least squares discriminant analysis score plot were used to segregate normal and CRC cells, as well as CRC cells in different stages of the disease. Variable importance in projection score identified unique differential metabolites in CRC cells of the different stages. We identified 7 differential metabolites unique to stage A, 3 in stage B, 5 in stage C, and 5 in stage D. Conclusion: This study highlights the differential metabolite profiling in CRC cell lines corresponding to different stages. The identification of the differential metabolites in CRC cells at individual stages will lead to a better understanding of the pathophysiology of CRC development and progression and, hence, its application in treatment strategies.
Keywords: Cell metabolomics; Colorectal cancer; Metabolites; Stages.
© 2021 The Author(s).
Similar articles
-
Metabolomic Profiling Identified Serum Metabolite Biomarkers and Related Metabolic Pathways of Colorectal Cancer.Dis Markers. 2021 Dec 7;2021:6858809. doi: 10.1155/2021/6858809. eCollection 2021. Dis Markers. 2021. PMID: 34917201 Free PMC article. Clinical Trial.
-
An Integrative Approach Using Molecular and Metabolomic Studies Reveals the Connection of Glutamic Acid with Telomerase and Oxidative Stress in Berberine-Treated Colorectal Cancer Cell Line HCT 116.Appl Biochem Biotechnol. 2025 Jun;197(6):3724-3747. doi: 10.1007/s12010-025-05200-9. Epub 2025 Feb 26. Appl Biochem Biotechnol. 2025. PMID: 40009339
-
Characterizing metabolic changes in human colorectal cancer.Anal Bioanal Chem. 2015 Jun;407(16):4581-95. doi: 10.1007/s00216-015-8662-x. Epub 2015 May 6. Anal Bioanal Chem. 2015. PMID: 25943258
-
Metabolomics Profiling on Different Stages of Colorectal Cancer: A Systematic Review.Malays J Med Sci. 2018 Sep;25(5):16-34. doi: 10.21315/mjms2018.25.5.3. Epub 2018 Oct 30. Malays J Med Sci. 2018. PMID: 30914860 Free PMC article. Review.
-
The Application of Metabolomics in Recent Colorectal Cancer Studies: A State-of-the-Art Review.Cancers (Basel). 2022 Jan 30;14(3):725. doi: 10.3390/cancers14030725. Cancers (Basel). 2022. PMID: 35158992 Free PMC article. Review.
Cited by
-
Determination of the Minimum Sample Amount for Capillary Electrophoresis-Fourier Transform Mass Spectrometry (CE-FTMS)-Based Metabolomics of Colorectal Cancer Biopsies.Biomedicines. 2023 Jun 13;11(6):1706. doi: 10.3390/biomedicines11061706. Biomedicines. 2023. PMID: 37371800 Free PMC article.
-
UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer.BMC Cancer. 2024 May 27;24(1):644. doi: 10.1186/s12885-024-12321-7. BMC Cancer. 2024. PMID: 38802800 Free PMC article.
-
Increased ENT2 expression and its association with altered purine metabolism in cell lines derived from different stages of colorectal cancer.Exp Ther Med. 2023 Mar 24;25(5):212. doi: 10.3892/etm.2023.11911. eCollection 2023 May. Exp Ther Med. 2023. PMID: 37123217 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Miscellaneous